IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $68.52 million. The enterprise value is $32.53 million.

Market Cap	68.52M
Enterprise Value	32.53M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 24.76% in one year.

Current Share Class	65.88M
Shares Outstanding	65.88M
Shares Change (YoY)	+24.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	14.52%
Float	31.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.44
P/TBV Ratio	2.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.07.

Current Ratio	2.32
Quick Ratio	2.03
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -138.78% and return on invested capital (ROIC) is -83.55%.

Return on Equity (ROE)	-138.78%
Return on Assets (ROA)	-70.13%
Return on Invested Capital (ROIC)	-83.55%
Return on Capital Employed (ROCE)	-355.42%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $1.17 million in taxes.

Income Tax	1.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.64% in the last 52 weeks. The beta is 0.09, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-24.64%
50-Day Moving Average	0.97
200-Day Moving Average	1.02
Relative Strength Index (RSI)	55.42
Average Volume (20 Days)	89,883

Short Selling Information

The latest short interest is 109,843, so 0.17% of the outstanding shares have been sold short.

Short Interest	109,843
Short Previous Month	112,344
Short % of Shares Out	0.17%
Short % of Float	0.35%
Short Ratio (days to cover)	0.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-97.56M
Pretax Income	-87.64M
Net Income	-98.46M
EBITDA	-97.31M
EBIT	-97.56M
Earnings Per Share (EPS)	-$1.49

Full Income Statement

Balance Sheet

The company has $37.09 million in cash and $1.76 million in debt, giving a net cash position of $35.32 million or $0.54 per share.

Cash & Cash Equivalents	37.09M
Total Debt	1.76M
Net Cash	35.32M
Net Cash Per Share	$0.54
Equity (Book Value)	26.42M
Book Value Per Share	0.40
Working Capital	24.06M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.76%
Shareholder Yield	-24.76%
Earnings Yield	-145.09%
FCF Yield	n/a

Analyst Forecast

The average price target for IO Biotech is $9.33, which is 797.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.33
Price Target Difference	797.12%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a